Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 23 | 2025 | 654 | 3.530 |
Why?
|
| Genetic Therapy | 26 | 2025 | 704 | 3.140 |
Why?
|
| Genetic Vectors | 21 | 2025 | 795 | 3.100 |
Why?
|
| Tay-Sachs Disease | 5 | 2022 | 34 | 2.240 |
Why?
|
| Sandhoff Disease | 11 | 2024 | 25 | 1.910 |
Why?
|
| Sheep | 8 | 2024 | 166 | 1.740 |
Why?
|
| Disease Models, Animal | 18 | 2025 | 2051 | 1.480 |
Why?
|
| Brain | 12 | 2025 | 1483 | 1.360 |
Why?
|
| Central Nervous System | 11 | 2024 | 190 | 1.330 |
Why?
|
| Gangliosidosis, GM1 | 4 | 2025 | 19 | 1.210 |
Why?
|
| Cats | 19 | 2024 | 81 | 1.150 |
Why?
|
| Transduction, Genetic | 6 | 2021 | 224 | 1.050 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2025 | 2022 | 1.000 |
Why?
|
| Cerebellopontine Angle | 1 | 2024 | 7 | 0.950 |
Why?
|
| Cisterna Magna | 2 | 2024 | 14 | 0.920 |
Why?
|
| Gene Transfer Techniques | 6 | 2024 | 304 | 0.900 |
Why?
|
| Huntington Disease | 2 | 2022 | 146 | 0.850 |
Why?
|
| Green Fluorescent Proteins | 1 | 2024 | 350 | 0.840 |
Why?
|
| beta-N-Acetylhexosaminidases | 7 | 2024 | 22 | 0.820 |
Why?
|
| Animals | 38 | 2025 | 19549 | 0.790 |
Why?
|
| Gene Expression | 4 | 2020 | 805 | 0.730 |
Why?
|
| White Matter | 1 | 2022 | 113 | 0.710 |
Why?
|
| Injections | 1 | 2020 | 79 | 0.700 |
Why?
|
| Thalamus | 1 | 2020 | 62 | 0.680 |
Why?
|
| Gangliosidoses, GM2 | 3 | 2024 | 6 | 0.650 |
Why?
|
| beta-Hexosaminidase alpha Chain | 1 | 2017 | 2 | 0.590 |
Why?
|
| beta-Hexosaminidase beta Chain | 1 | 2017 | 2 | 0.590 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2020 | 265 | 0.550 |
Why?
|
| Biomarkers | 4 | 2023 | 1202 | 0.540 |
Why?
|
| Cat Diseases | 3 | 2023 | 16 | 0.510 |
Why?
|
| Tissue Distribution | 4 | 2024 | 280 | 0.510 |
Why?
|
| Transgenes | 4 | 2022 | 170 | 0.430 |
Why?
|
| Capsid Proteins | 3 | 2021 | 94 | 0.430 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2024 | 132 | 0.390 |
Why?
|
| Neurodegenerative Diseases | 2 | 2023 | 127 | 0.360 |
Why?
|
| Humans | 23 | 2025 | 59047 | 0.330 |
Why?
|
| Phenotype | 2 | 2024 | 1152 | 0.270 |
Why?
|
| Disease Progression | 5 | 2025 | 1037 | 0.260 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2025 | 9 | 0.250 |
Why?
|
| G(M2) Activator Protein | 1 | 2024 | 1 | 0.240 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2025 | 18 | 0.240 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 852 | 0.240 |
Why?
|
| Precision Medicine | 2 | 2023 | 102 | 0.240 |
Why?
|
| Genes, Reporter | 3 | 2019 | 243 | 0.230 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2023 | 5 | 0.220 |
Why?
|
| Skin Abnormalities | 1 | 2023 | 8 | 0.220 |
Why?
|
| Neuroimaging | 1 | 2024 | 130 | 0.220 |
Why?
|
| Anticonvulsants | 2 | 2022 | 94 | 0.210 |
Why?
|
| Catheters | 2 | 2019 | 66 | 0.210 |
Why?
|
| Homeostasis | 1 | 2025 | 340 | 0.200 |
Why?
|
| Mutant Proteins | 1 | 2022 | 103 | 0.190 |
Why?
|
| Mutation | 4 | 2023 | 2421 | 0.190 |
Why?
|
| Huntingtin Protein | 2 | 2019 | 138 | 0.190 |
Why?
|
| C9orf72 Protein | 1 | 2021 | 98 | 0.180 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 20 | 0.180 |
Why?
|
| Growth Plate | 1 | 2020 | 14 | 0.180 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 148 | 0.170 |
Why?
|
| Brain Diseases | 1 | 2020 | 67 | 0.170 |
Why?
|
| Lysosomes | 3 | 2015 | 162 | 0.170 |
Why?
|
| Antigens, Ly | 1 | 2019 | 40 | 0.170 |
Why?
|
| Injections, Spinal | 1 | 2019 | 43 | 0.170 |
Why?
|
| Cryotherapy | 1 | 2019 | 12 | 0.170 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 34 | 0.170 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 54 | 0.170 |
Why?
|
| Phosphoproteins | 1 | 2020 | 216 | 0.170 |
Why?
|
| Polysaccharides | 1 | 2020 | 144 | 0.160 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 82 | 0.160 |
Why?
|
| Video Recording | 1 | 2019 | 123 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 253 | 0.160 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 281 | 0.160 |
Why?
|
| Models, Animal | 1 | 2019 | 219 | 0.160 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2019 | 71 | 0.160 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 559 | 0.150 |
Why?
|
| Microglia | 2 | 2017 | 227 | 0.150 |
Why?
|
| Mice | 8 | 2025 | 10225 | 0.140 |
Why?
|
| Hypocalcemia | 1 | 2017 | 16 | 0.140 |
Why?
|
| Male | 8 | 2025 | 27385 | 0.140 |
Why?
|
| G(M2) Ganglioside | 3 | 2024 | 9 | 0.140 |
Why?
|
| Electroencephalography | 1 | 2017 | 134 | 0.130 |
Why?
|
| beta-Galactosidase | 3 | 2023 | 80 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 290 | 0.130 |
Why?
|
| Viral Tropism | 1 | 2016 | 54 | 0.130 |
Why?
|
| Mucopolysaccharidoses | 1 | 2015 | 2 | 0.130 |
Why?
|
| Animal Structures | 1 | 2015 | 3 | 0.130 |
Why?
|
| Brain Ischemia | 1 | 2019 | 403 | 0.120 |
Why?
|
| Muscles | 1 | 2016 | 171 | 0.120 |
Why?
|
| Adenoviridae | 1 | 2015 | 119 | 0.120 |
Why?
|
| Mental Disorders | 1 | 2022 | 763 | 0.120 |
Why?
|
| Echocardiography | 1 | 2017 | 455 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2019 | 839 | 0.110 |
Why?
|
| Gangliosides | 3 | 2022 | 19 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 254 | 0.110 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 94 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1538 | 0.100 |
Why?
|
| Peptides | 1 | 2015 | 547 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1453 | 0.100 |
Why?
|
| Drug Administration Routes | 2 | 2021 | 20 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2017 | 5129 | 0.100 |
Why?
|
| Primates | 2 | 2021 | 40 | 0.090 |
Why?
|
| Stroke | 1 | 2019 | 1135 | 0.090 |
Why?
|
| Astrocytes | 2 | 2020 | 114 | 0.080 |
Why?
|
| Female | 4 | 2025 | 30684 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 1219 | 0.070 |
Why?
|
| Aged | 1 | 2022 | 13264 | 0.070 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2024 | 10 | 0.060 |
Why?
|
| Atrophy | 1 | 2025 | 64 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2021 | 1466 | 0.060 |
Why?
|
| Child | 2 | 2025 | 4258 | 0.060 |
Why?
|
| Cattle | 1 | 2025 | 307 | 0.060 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 56 | 0.060 |
Why?
|
| Collagen Type V | 1 | 2023 | 2 | 0.060 |
Why?
|
| Neurons | 2 | 2021 | 854 | 0.060 |
Why?
|
| Whole Genome Sequencing | 1 | 2023 | 60 | 0.050 |
Why?
|
| Multiple Organ Failure | 1 | 2023 | 43 | 0.050 |
Why?
|
| Collagen | 1 | 2023 | 121 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 119 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 135 | 0.050 |
Why?
|
| G(M1) Ganglioside | 1 | 2022 | 9 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2022 | 37 | 0.050 |
Why?
|
| Quality of Life | 2 | 2022 | 1103 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2025 | 1054 | 0.050 |
Why?
|
| Motor Activity | 1 | 2024 | 342 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 95 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2021 | 81 | 0.050 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 25 | 0.040 |
Why?
|
| Liver | 1 | 2025 | 780 | 0.040 |
Why?
|
| Phospholipids | 1 | 2020 | 81 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2021 | 228 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2020 | 8 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2020 | 59 | 0.040 |
Why?
|
| Infant | 1 | 2025 | 1518 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2021 | 265 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2021 | 366 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 248 | 0.040 |
Why?
|
| Half-Life | 1 | 2019 | 70 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 71 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2025 | 1823 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2019 | 128 | 0.040 |
Why?
|
| Hypothermia, Induced | 1 | 2019 | 41 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 148 | 0.040 |
Why?
|
| Species Specificity | 1 | 2019 | 335 | 0.040 |
Why?
|
| Carotid Artery, Internal | 1 | 2019 | 66 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2019 | 105 | 0.040 |
Why?
|
| Swine | 1 | 2020 | 337 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 171 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 344 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 219 | 0.040 |
Why?
|
| Dogs | 1 | 2019 | 313 | 0.040 |
Why?
|
| Genotype | 1 | 2019 | 642 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 3180 | 0.040 |
Why?
|
| Gliosis | 1 | 2016 | 27 | 0.030 |
Why?
|
| Genes, MHC Class II | 1 | 2016 | 36 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 673 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 984 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 102 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 191 | 0.030 |
Why?
|
| Cerebrosides | 1 | 2015 | 2 | 0.030 |
Why?
|
| Sulfoglycosphingolipids | 1 | 2015 | 2 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 498 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 2014 | 17 | 0.030 |
Why?
|
| Young Adult | 1 | 2025 | 4300 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 41 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 846 | 0.030 |
Why?
|
| Breeding | 1 | 2014 | 26 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 500 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2015 | 195 | 0.030 |
Why?
|
| Adolescent | 1 | 2025 | 5895 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 415 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 178 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 238 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2016 | 762 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2014 | 553 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 3079 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 1114 | 0.020 |
Why?
|
| Cell Line | 1 | 2015 | 2011 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1444 | 0.020 |
Why?
|
| United States | 1 | 2022 | 7458 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2016 | 1453 | 0.020 |
Why?
|
| Adult | 1 | 2025 | 15669 | 0.020 |
Why?
|